{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:53:45Z","timestamp":1769162025347,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A growing consensus seems to be emerging that dexamethasone is a crucial component in the treatment of COVID-19-associated oxygen-dependent respiratory failure. Although dexamethasone has an undeniably beneficial effect on the inflammatory response in a subgroup of patients, the potential negative effects of corticosteroids must also be considered. In view of these negative effects, we argue that a one-size-fits-all dexamethasone approach may be potentially harmful in specific subsets of patients with COVID-19-associated ARDS. We propose a different individually tailored treatment strategy based on the patient\u2019s inflammatory response.<\/jats:p>","DOI":"10.1186\/s13054-021-03607-4","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T20:02:26Z","timestamp":1621972946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?\u2014a viewpoint"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-9212","authenticated-orcid":false,"given":"Marnix","family":"Kuindersma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio Ramos","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"1","key":"3607_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13054-020-03218-5","volume":"24","author":"M Remmelink","year":"2020","unstructured":"Remmelink M, De Mendon\u00e7a R, D\u2019Haene N, De Clercq S, Verocq C, Lebrun L, et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care. 2020;24(1):495.","journal-title":"Crit Care"},{"issue":"10","key":"3607_CR2","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135\u201340.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"3607_CR3","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537.","journal-title":"Autoimmun Rev"},{"key":"3607_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","volume":"8","author":"DE Leisman","year":"2020","unstructured":"Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233\u201344.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"3607_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","volume":"202","author":"OJ McElvaney","year":"2020","unstructured":"McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202(6):812\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"3607_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.17052","volume":"324","author":"M Kox","year":"2020","unstructured":"Kox M, Waalders NJB, Kooistra EJ, Gerretsen J, Pickkers P. Cytokine levels in critically Ill patients with COVID-19 and other conditions. JAMA. 2020;324(15):1565\u20137. https:\/\/doi.org\/10.1001\/jama.2020.17052.","journal-title":"JAMA"},{"issue":"10","key":"3607_CR7","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(20)30275-7","volume":"2","author":"JJ Manson","year":"2020","unstructured":"Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol. 2020;2(10):e594\u2013602.","journal-title":"Lancet Rheumatol"},{"issue":"8","key":"3607_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611\u201320.","journal-title":"Lancet Respir Med"},{"key":"3607_CR9","doi-asserted-by":"crossref","unstructured":"Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020.","DOI":"10.1093\/cid\/ciaa954"},{"issue":"5","key":"3607_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2020.10044","volume":"324","author":"L Li","year":"2020","unstructured":"Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):460\u201370.","journal-title":"JAMA"},{"issue":"8","key":"3607_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"key":"3607_CR12","doi-asserted-by":"crossref","unstructured":"Annane D, S\u00e9bille V, Bellissant E, Group G-I-S. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med. 2006; 34(1):22\u201330.","DOI":"10.1097\/01.CCM.0000194723.78632.62"},{"issue":"16","key":"3607_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671\u201384.","journal-title":"N Engl J Med"},{"issue":"1","key":"3607_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329.","journal-title":"Crit Care"},{"issue":"4","key":"3607_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1378\/chest.06-2100","volume":"131","author":"GU Meduri","year":"2007","unstructured":"Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954\u201363.","journal-title":"Chest"},{"issue":"5","key":"3607_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","volume":"42","author":"GU Meduri","year":"2016","unstructured":"Meduri GU, Bridges L, Shih MC, Marik PE, Siemieniuk RAC, Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829\u201340.","journal-title":"Intensive Care Med"},{"issue":"3","key":"3607_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, Ambr\u00f3s A, Mu\u00f1oz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"3607_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43(12):1751\u201363.","journal-title":"Intensive Care Med"},{"issue":"11","key":"3607_CR19","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00134-020-06223-y","volume":"46","author":"YM Arabi","year":"2020","unstructured":"Arabi YM, Chrousos GP, Meduri GU. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Intensive Care Med. 2020;46(11):2067\u201370.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3607_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3892\/etm.2017.4154","volume":"13","author":"ZG Yang","year":"2017","unstructured":"Yang ZG, Lei XL, Li XL. Early application of low-dose glucocorticoid improves acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Exp Ther Med. 2017;13(4):1215\u201324.","journal-title":"Exp Ther Med"},{"key":"3607_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40560-020-00464-1","volume":"8","author":"Y Zayed","year":"2020","unstructured":"Zayed Y, Barbarawi M, Ismail E, Samji V, Kerbage J, Rizk F, et al. Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis. J Intensive Care. 2020;8:43.","journal-title":"J Intensive Care"},{"issue":"1","key":"3607_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","volume":"23","author":"YN Ni","year":"2019","unstructured":"Ni YN, Chen G, Sun J, Liang BM, Liang ZA. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care. 2019;23(1):99.","journal-title":"Crit Care"},{"issue":"4","key":"3607_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","volume":"31","author":"N Lee","year":"2004","unstructured":"Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. 2004;31(4):304\u20139.","journal-title":"J Clin Virol"},{"issue":"13","key":"3607_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","volume":"324","author":"PF Dequin","year":"2020","unstructured":"Dequin PF, Heming N, Meziani F, Plantef\u00e8ve G, Voiriot G, Badi\u00e9 J, et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically Ill patients with COVID-19: a randomized clinical trial. JAMA. 2020;324(13):1298\u2013306.","journal-title":"JAMA"},{"issue":"13","key":"3607_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307\u201316.","journal-title":"JAMA"},{"issue":"13","key":"3607_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324(13):1317\u201329.","journal-title":"JAMA"},{"key":"3607_CR27","unstructured":"Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020."},{"issue":"1","key":"3607_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s13054-020-03360-0","volume":"24","author":"D De Backer","year":"2020","unstructured":"De Backer D, Azoulay E, Vincent JL. Corticosteroids in severe COVID-19: a critical view of the evidence. Crit Care. 2020;24(1):627.","journal-title":"Crit Care"},{"key":"3607_CR29","unstructured":"Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med. 2021."},{"issue":"10285","key":"3607_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"Group RC","year":"2021","unstructured":"Group RC. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637\u201345.","journal-title":"Lancet"},{"key":"3607_CR31","doi-asserted-by":"crossref","unstructured":"Rosas IO, Br\u00e4u N, Waters M, Go RC, Hunter BD, Bhagani S, et al. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021.","DOI":"10.1056\/NEJMoa2028700"},{"key":"3607_CR32","doi-asserted-by":"publisher","unstructured":"Wang SY, Chang CH, Meizlish ML, Bahel P, Rinder HM, Lee AI, et al. Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19. medRxiv. 2020; doi: https:\/\/doi.org\/10.1101\/2020.12.23.20248547. Preprint","DOI":"10.1101\/2020.12.23.20248547"},{"issue":"12","key":"3607_CR33","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1007\/s00134-020-06289-8","volume":"46","author":"GU Meduri","year":"2020","unstructured":"Meduri GU, Annane D, Confalonieri M, Chrousos GP, Rochwerg B, Busby A, et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med. 2020;46(12):2284\u201396.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3607_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13054-018-2111-0","volume":"22","author":"T Yang","year":"2018","unstructured":"Yang T, Li Z, Jiang L, Xi X. Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis. Crit Care. 2018;22(1):187.","journal-title":"Crit Care"},{"issue":"11","key":"3607_CR35","doi-asserted-by":"publisher","first-page":"e0244","DOI":"10.1097\/CCE.0000000000000244","volume":"2","author":"P Chauvet","year":"2020","unstructured":"Chauvet P, Mallat J, Arumadura C, Vangrunderbeek N, Dupre C, Pauquet P, et al. Risk factors for invasive pulmonary aspergillosis in critically Ill patients with coronavirus disease 2019-induced acute respiratory distress syndrome. Crit Care Explor. 2020;2(11):e0244.","journal-title":"Crit Care Explor"},{"issue":"10","key":"3607_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"AFAD Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782\u201392.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3607_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00134-004-2509-9","volume":"31","author":"R Amaya-Villar","year":"2005","unstructured":"Amaya-Villar R, Garnacho-Montero J, Garc\u00eda-Garmend\u00eda JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med. 2005;31(1):157\u201361.","journal-title":"Intensive Care Med"},{"issue":"5","key":"3607_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/thoraxjnl-2017-211090","volume":"73","author":"K Delucchi","year":"2018","unstructured":"Delucchi K, Famous KR, Ware LB, Parsons PE, Thompson BT, Calfee CS, et al. Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax. 2018;73(5):439\u201345.","journal-title":"Thorax"},{"issue":"8","key":"3607_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.12788\/jhm.3497","volume":"15","author":"MJ Keller","year":"2020","unstructured":"Keller MJ, Kitsis EA, Arora S, Chen JT, Agarwal S, Ross MJ, et al. Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19. J Hosp Med. 2020;15(8):489\u201393.","journal-title":"J Hosp Med"},{"key":"3607_CR40","unstructured":"Epidemiology and clinical manifestations of invasive aspergillosis. [Internet]. 2019."},{"key":"3607_CR41","doi-asserted-by":"publisher","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020 Dec 14; doi: https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1. Online ahead of print.","DOI":"10.1016\/S1473-3099(20)30847-1"},{"issue":"2","key":"3607_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamainternmed.2019.5713","volume":"180","author":"CE Luyt","year":"2020","unstructured":"Luyt CE, Forel JM, Hajage D, Jaber S, Cayot-Constantin S, Rimmel\u00e9 T, et al. Acyclovir for mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: a randomized clinical trial. JAMA Intern Med. 2020;180(2):263\u201372.","journal-title":"JAMA Intern Med"},{"key":"3607_CR43","doi-asserted-by":"publisher","unstructured":"Saris A, Reijnders TD, Nossent EJ, Schuurman AR, Verhoeff J, Asten SV, et al. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorax. 2021 Apr 12; doi: https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216256. Online ahead of print.","DOI":"10.1136\/thoraxjnl-2020-216256"},{"issue":"6","key":"3607_CR44","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26(6):842\u20134.","journal-title":"Nat Med"},{"issue":"10238","key":"3607_CR45","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF Hung","year":"2020","unstructured":"Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395(10238):1695\u2013704.","journal-title":"Lancet"},{"key":"3607_CR46","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515)."},{"issue":"6","key":"3607_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"H Pan","year":"2021","unstructured":"Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, et al. Repurposed antiviral drugs for Covid-19 - interim WHO solidarity trial results. N Engl J Med. 2021;384(6):497\u2013511.","journal-title":"N Engl J Med"},{"key":"3607_CR48","doi-asserted-by":"publisher","first-page":"603961","DOI":"10.3389\/fmed.2020.603961","volume":"7","author":"C Ruetsch","year":"2020","unstructured":"Ruetsch C, Brglez V, Cr\u00e9moni M, Zorzi K, Fernandez C, Boyer-Suavet S, et al. Functional exhaustion of Type I and II interferons production in severe COVID-19 patients. Front Med (Lausanne). 2020;7:603961.","journal-title":"Front Med (Lausanne)"},{"key":"3607_CR49","doi-asserted-by":"publisher","first-page":"118166","DOI":"10.1016\/j.lfs.2020.118166","volume":"258","author":"G Morris","year":"2020","unstructured":"Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O\u2019Neil A, et al. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach. Life Sci. 2020;258:118166.","journal-title":"Life Sci"},{"issue":"3","key":"3607_CR50","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.1300132","volume":"191","author":"I Kyrmizi","year":"2013","unstructured":"Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, et al. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1\/Syk kinase signaling. J Immunol. 2013;191(3):1287\u201399.","journal-title":"J Immunol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-021-03607-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T20:04:38Z","timestamp":1621973078000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3607"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03607-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"4 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}